ATE350056T1 - Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems - Google Patents
Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystemsInfo
- Publication number
- ATE350056T1 ATE350056T1 AT01922507T AT01922507T ATE350056T1 AT E350056 T1 ATE350056 T1 AT E350056T1 AT 01922507 T AT01922507 T AT 01922507T AT 01922507 T AT01922507 T AT 01922507T AT E350056 T1 ATE350056 T1 AT E350056T1
- Authority
- AT
- Austria
- Prior art keywords
- viruses
- cold
- equine influenza
- influenza virus
- influenza
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 241000700605 Viruses Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title 1
- 210000002345 respiratory system Anatomy 0.000 title 1
- 241000283073 Equus caballus Species 0.000 abstract 7
- 241000712461 unidentified influenza virus Species 0.000 abstract 7
- 230000001225 therapeutic effect Effects 0.000 abstract 5
- 241000712431 Influenza A virus Species 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000012678 infectious agent Substances 0.000 abstract 3
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 241000283086 Equidae Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16164—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19432500P | 2000-04-03 | 2000-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350056T1 true ATE350056T1 (de) | 2007-01-15 |
Family
ID=22717146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01922507T ATE350056T1 (de) | 2000-04-03 | 2001-03-21 | Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7029903B2 (enExample) |
| EP (1) | EP1267920B1 (enExample) |
| JP (1) | JP2003528925A (enExample) |
| AT (1) | ATE350056T1 (enExample) |
| AU (2) | AU4930001A (enExample) |
| CA (1) | CA2403979A1 (enExample) |
| DE (1) | DE60125736D1 (enExample) |
| WO (1) | WO2001074386A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004003572A1 (de) | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
| US7572620B2 (en) | 2005-01-11 | 2009-08-11 | Wisconsin Alumni Research Foundation | H3 equine influenza A virus |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| EP2407480B1 (en) * | 2005-10-19 | 2014-07-16 | University of Florida Research Foundation, Incorporated | Materials for respiratory disease control in canines |
| EP2391713A1 (en) | 2009-01-30 | 2011-12-07 | The Board Of Regents For Oklahoma State University | Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs |
| KR101793195B1 (ko) | 2009-03-27 | 2017-11-02 | 아카데미아 시니카 | 바이러스에 대한 면역을 위한 방법 및 조성물 |
| AU2011224507A1 (en) * | 2010-03-10 | 2012-08-30 | Intervet International B.V. | Method for protecting against disease caused by secondary pathogens |
| TWI537385B (zh) | 2010-11-04 | 2016-06-11 | 中央研究院 | 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法 |
| CA2874966C (en) * | 2012-05-31 | 2020-06-09 | Zoetis Services Llc | Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections |
| JP6560056B2 (ja) * | 2015-08-07 | 2019-08-14 | ウィスコンシン アルムニ リサーチ ファンデイション | Ｈ３型ウマａ型インフルエンザウイルス |
| JP2018088928A (ja) * | 2018-02-13 | 2018-06-14 | ウィスコンシン アルムニ リサーチ ファンデイション | Ｈ３型ウマａ型インフルエンザウイルス |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3518347A (en) | 1965-05-28 | 1970-06-30 | Inst Microbiologie Et D Hygien | Vaccine for equine influenza |
| US3992522A (en) | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
| WO1983003546A1 (en) | 1982-04-16 | 1983-10-27 | Cornell Res Foundation Inc | Temperature sensitive reassortant viruses and a vaccine against equine influenza |
| US4683137A (en) | 1982-04-16 | 1987-07-28 | Cornell Research Foundation, Inc. | Temperature sensitive reassortant viruses and a vaccine against equine influenza |
| GB8300467D0 (en) | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
| US4920213A (en) | 1985-06-20 | 1990-04-24 | Biotechnology Research Partners, Ltd. | Method and compositions useful in preventing equine influenza |
| US4631191A (en) | 1985-06-20 | 1986-12-23 | Biotechnology Research Partners, Ltd. | Methods and compositions useful in preventing equine influenza |
| US5149531A (en) | 1990-06-27 | 1992-09-22 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza |
| IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
| US5690937A (en) | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
| US6177082B1 (en) * | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
-
2001
- 2001-03-21 AU AU4930001A patent/AU4930001A/xx active Pending
- 2001-03-21 DE DE60125736T patent/DE60125736D1/de not_active Expired - Lifetime
- 2001-03-21 JP JP2001572128A patent/JP2003528925A/ja active Pending
- 2001-03-21 WO PCT/US2001/008968 patent/WO2001074386A2/en not_active Ceased
- 2001-03-21 EP EP01922507A patent/EP1267920B1/en not_active Expired - Lifetime
- 2001-03-21 AU AU2001249300A patent/AU2001249300B2/en not_active Expired
- 2001-03-21 CA CA002403979A patent/CA2403979A1/en not_active Abandoned
- 2001-03-21 US US10/239,972 patent/US7029903B2/en not_active Expired - Lifetime
- 2001-03-21 AT AT01922507T patent/ATE350056T1/de not_active IP Right Cessation
-
2006
- 2006-01-17 US US11/332,989 patent/US20060121521A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1267920B1 (en) | 2007-01-03 |
| WO2001074386A3 (en) | 2002-05-23 |
| JP2003528925A (ja) | 2003-09-30 |
| DE60125736D1 (de) | 2007-02-15 |
| EP1267920A2 (en) | 2003-01-02 |
| AU4930001A (en) | 2001-10-15 |
| CA2403979A1 (en) | 2001-10-11 |
| WO2001074386A2 (en) | 2001-10-11 |
| US20060121521A1 (en) | 2006-06-08 |
| AU2001249300B2 (en) | 2006-02-16 |
| US7029903B2 (en) | 2006-04-18 |
| US20040223980A1 (en) | 2004-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1105497T3 (da) | Koldadapterede hesteinfluenzavira | |
| WO2001060849A3 (en) | Cold-adapted equine influenza viruses | |
| DE60125736D1 (de) | Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems | |
| TW200730188A (en) | Vaccines and methods to treat canine influenza | |
| Zheng et al. | Intranasal administration of chitosan against influenza A (H7N9) virus infection in a mouse model | |
| MX9700229A (es) | Vacuna de polinucleotido para virus de papiloma. | |
| ATE476983T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege | |
| DE602004017481D1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| Bray | Highly pathogenic RNA viral infections: challenges for antiviral research | |
| CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| BR0015398A (pt) | Vacinas para mycoplasma bovis e processos de uso | |
| Yousaf et al. | Crimean-Congo hemorrhagic fever (CCHF) in Pakistan: the" Bell" is ringing silently | |
| CL2022002412A1 (es) | Vacuna | |
| ATE298568T1 (de) | Albumin-bindende verbindungen die die nichtenzymatische glycosylierung verhindern und die zur behandlung von glycosylierungsbedingten erkrankungen verwendet werden können | |
| JP2003528925A5 (enExample) | ||
| MX2025012908A (es) | Composicion inmunogenica util para la autoadministracion por cerdos | |
| BR0209251A (pt) | Vacina contra vìrus da febre aftosa | |
| HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
| Dowling et al. | Cold-adapted equine influenza viruses | |
| Warfield et al. | Filovirus infections | |
| DK1132466T3 (da) | Kyllingeanæmivira med lav patogenicitet | |
| Thomson et al. | Foot and Mouth Disease in Southern Africa: Re-evaluation of the approach to control | |
| NO20014372D0 (no) | Isolering og delvis karakterisering av en ny antiprokferativ komponent fra humane leukocytter | |
| Iqbal | MYTHS AND MYSTERIES ABOUT COVID-19: LESSONS FOR PAKISTAN | |
| Oxford et al. | The threat of avian influenza H5N1:‘do we have the tools for the job?’ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |